Partnerships in Clinical Trials Asia

·         Hear in-depth case studies on strategic partnering and effective outsourcing to ensure quality, control costs and accelerate cures to market

·         Explore new business opportunities and strategies to bring more innovation to Asia

·         Hear from the SFDA on updates on clinical safety and monitoring guidelines

·         Understand how global clinical leaders are incorporating China into their global drug development strategy

·         Gain insights into the regulatory landscapes in Japan, India, Korea, Taiwan, China, and more

·         Obtain strategies for partnering in specific therapeutic areas by hearing proven case studies in oncology, CNS, Cardiovascular, and vaccine development

·         Develop strategies to improve sponsor, CRO, and site collaborations in Asia

·         Learn about trends in patient recruitment efforts across the region and develop strategies to suit Asian cultures

·         Examine level of data quality in the region and overcome challenges in GCP implementation

·         Identify new trends in technology impacting clinical development in Asia and exchange best practices on data management

Gather unique insights from industry leaders including:

 ·         John Hubbard, SVP Global Drug Development, Pfizer Inc, USA

·         Donald Russell, Senior Director, International Clinical Operations, Eli Lilly and Co, USA

·         Vance Warren, Senior Study Logistics Manager Translational Medicine Clinical Pharmacology, Daiichi Sankyo Pharma Development, USA

·         Ling Su, Senior Vice President & Head of Development Greater China, Novartis Pharmaceuticals

·         Shirley Zhao, Managing Director, Genzyme

·         Rebecca Wang, Head of Product Safety Operation- Asia Pacific, Roche·         Ross Horsburgh, Vice President Clinical Development, Nycomed

·         Li Ding, Head of Trial Operations- China and APAC, Clinical Science and Operations, Sanofi Aventis

·         Wenmin Du, Executive Director, SFDA, China

·         Vincenzo Teneggi, Head of Early Development & Clinical Pharmacology, Asia Pacific, Roche

·         Yutaka Natsumeda, Director of Office of Clinical Trials, Yokohama City University Hospital

·         Chichang Lee, Executive Director, Simcere Pharmaceuticals

·         Helen Jiang, Vice President Clinical, Hengrui PharmaceuticalsAnd more…

And while site and investigator quality and the availability of naïve patient populations in some Asian countries may be unparalleled, Asia-based trials present their own unique operational, regulatory, technological, logistical, and ethical challenges. 

Join this premiere clinical partnering event accelerating the progress of clinical trials around the world. 

For full and updated programme details, log on to www.clinicalpartnershipsasia.com or

simply email us at register@ibcasia.com.sg /